Oxford Nanopore at AMP 2026
Overview
The Association for Molecular Pathology (AMP) Annual Meeting & Expo features more than 200 exhibiting companies, 60 educational sessions, nearly 400 poster presentations, and 3,000+ attendees/exhibitors.
Oxford Nanopore will be located at Booth 604, and will host 2 Corporate Workshops on Wednesday, November 11.
Exhibits will be open from November 12 to November 14.
Oncology Workshop
Rapid tumor profiling with real-time nanopore sequencing
Molecular diagnosis and methylation-based classification are increasingly important for the comprehensive characterization of cancer. In this sponsored session, speakers will demonstrate how Oxford Nanopore native DNA sequencing and Adaptive Sampling can enable rapid profiling of CNS tumors and leukemia. Adaptive Sampling provides software-defined, on-sequencer target enrichment with low-pass whole genome, without the need for baits or a lengthy enrichment workflow. Combined with real-time sequencing and direct detection of DNA methylation, this approach accelerates access to rich genomic and epigenomic insights. Speakers will highlight how rapid methylation-based classification alongside genomic analysis is advancing molecular testing workflows and explore its potential for clinical implementation.
Date: Wednesday, November 11, 2026
Time: 12:00 pm-12:50 pm PST
Location: Tahoma 1, Level 3, Arch at 800 Pike
Rare Disease Workshop
Enabling more complete rare disease analysis with long-read sequencing
Rare disease research requires the detection of complex genomic variation that can be challenging to capture using traditional short-read sequencing approaches alone. This workshop will provide an overview of how long-read sequencing technologies are expanding genomic analysis through more comprehensive characterization of structural variants, repeat expansions, and other difficult-to-resolve genomic features. Through case studies and practical examples, attendees will explore how long-read sequencing can uncover biologically relevant variation missed by conventional methods, improving the resolution of challenging genomic regions, and broadening the scope of rare disease studies.
Date: Wednesday, November 11, 2026
Time: 01:00 pm-01:50 pm PST
Location: Tahoma 4, Level 3, Arch at 800 Pike
:quality(80))